Tsuruha Holdings shares come into this earnings recap under pressure, with the stock down roughly 9.5% over the past month even after a flat week. That cautious mood meets a pharmacy chain still reporting profit per share, with Q2 basic earnings at ¥36.99 and trailing twelve month basic EPS at ¥131.37.

The main focus for sentiment is on the balance sheet rather than the income statement. Recent shareholder dilution hangs over a business trading on an 18.2x P/E, while a discounted cash flow view suggests the current ¥2,114 price implies a steep valuation gap.

Is Tsuruha Holdings a genuine bargain at a 69.5% discount to a DCF estimate, or is that gap simply flagging hidden risks ahead? Compare the current share price against intrinsic…